A Proof of Concept Window Trial of the IMmunological Effects of AveLumab and Aspirin in Triple-Negative Breast Cancer

NCT04188119 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to open

Conditions

Breast Cancer

Interventions

DRUG: Avelumab
DRUG: Aspirin
DRUG: Lansoprazole

Sponsor

The Christie NHS Foundation Trust